The SALL4-specific T cell response was the strongest, followed by MAGE-A3, NY-ESO-1, MAGE-A1 and SSX2, in early-stage HCC patients, whereas the AFP-specific T cell response was the highest in advanced HCC patients. Here, SALL4 is linked to hepatocellular carcinoma.